financial assistance for glp 1 MCT2D GLP-1s for Financial Freedom |

In the Phase 2 trial published in the New England Journal of Medicine, participants receiving the highest dose of retatrutide (12mg weekly) achieved a mean body weight reduction of 24.2% over 48 weeks

They noted that many southern states with high prevalence rates of obesity also have higher prescription fill rates for GLP-1s

avoid high-fat foods

GIP enhances the metabolic flexibility allowing tissues to utilize both glucose and fatty acids efficiently

The addressable patient expansion is estimated to grow the anti-obesity medication market by 180 million new prescription patients between 2027 and 2032

Glucagon-like peptide-1 regulation by food proteins and protein hydrolysates